Table: begin end state 1 25 cytoplasmic 26 43 transmembrane 44 56 non-cytoplasmic 57 77 transmembrane 78 82 cytoplasmic 83 102 transmembrane 103 107 non-cytoplasmic 108 129 transmembrane 130 135 cytoplasmic 136 157 transmembrane 158 187 non-cytoplasmic 188 206 transmembrane 207 225 cytoplasmic 226 245 transmembrane 246 250 non-cytoplasmic 251 268 transmembrane 269 297 cytoplasmic 298 319 transmembrane 320 335 non-cytoplasmic 336 351 transmembrane 352 352 non-cytoplasmic 353 353 cytoplasmic 354 378 transmembrane 379 383 cytoplasmic 384 392 transmembrane 393 403 cytoplasmic
Input: >AZOBR_RS31250 FitnessBrowser__azobra:AZOBR_RS31250 MSAELNLPARGPRVSMGRFVKAHMREYGMLLSLVAIVLFFQYMTDGTLLQPLNLTNLVLQ NSYIVIMALGMLLVIVAGHIDLSVGSVVALIGALAATLMVRLHLDFVTTTLLCLLAGAAI GAVQGFWVAYLRIPSFIVTLAGMLVFRGLCLILLAGQSVGPFPVEFQRLSSGFIPDFLAL DALNLGKFHLTSLLLCAAVAAAMVAMNTRARLRRQSVAIEQEPLPLFVAKNVALAAVLIY VGQLMASYRGLPNVLIIMSVLIALYSFVTRNTTVGRRVYALGGNEKAAKLSGIDTRRLSF YTFVNMGVLAALAGLIFAARLNTATPKAGASFELDVIAACFIGGASASGGVGRVTGAVIG AFIMGVMNNGMSILGIGIDWQQVIKGMVLLAAVTIDVYNKNKA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server